Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy
British Journal of Clinical Pharmacology · 2026-10 · 92 (10) · 3586-3597
DOI: 10.1002/bcp.70645 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 01.07.2026. Verfasst von Hannah Johnson und 22 weiteren Autor:innen. Beteiligte Einrichtung: City St George's (School of Health & Medical Sciences), London, UK. Hauptthemen laut MEDLINE: Pharmacovigilance, Abnormalities, Drug-Induced, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Aim
Many women take medications during pregnancy. However, the risk to the fetus from most medications is uncertain. Congenital anomalies are one of the leading causes of infant death and contribute to long‐term disability. Signal detection methods can be used to systematically identify possible medication–anomaly associations that require further investigation.
Methods
Data on first trimester medication exposures in pregnancies with a congenital anomaly reported to 14 EUROmediCAT registries with a birth year of 2005–2018 were analysed. Case‐malformed disproportionality analysis identified medication–anomaly signals using a disproportionality signal detection method. Identified signals were then compared to previous EUROmediCAT signal detection studies and ranked based on a proxy for the severity of impact at a population level using the number of estimated excess congenital anomaly cases within the exposed population and the average additional time in hospital over the first year of life. Generalized linear mixed models were used to assess confounding by birth year and registry within the top 20 ranked signals.
Results
1611 medication–outcome pairs with at least three observations were analysed, and 153 signals for 63 different medications were identified. Of the top 20 ranked signals, 10 (involving nine medications) were prioritized for further independent investigation.
Conclusion
The signals identified here are hypothesis forming only. Independent studies that adequately account for confounding are subsequently needed to evaluate if the identified signals are causal. Further investigation of signals with low population impact, but high potential individual risk is also recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- City St George's (School of Health & Medical Sciences), London, UK.
- School of Medicine, Ulster University, Londonderry, UK.
- Institute of Nursing and Health Research, Ulster University, Northern Ireland, UK.
- Faculté de Médecine, CERPOP UMR INSERM, Centre Hospitalier Universitaire, Université Toulouse, Toulouse, France.
- Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway.
- Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.
ORCID-Profile: Hannah Johnson, Helen Dolk, Maria Loane, Christine Damase-Michel, Joanne Given, Hedvig Nordeng, Jorieke E H Bergman, Iain Carey, Elly Den Hond, Ester Garne, Florence Rouget, Lea Bruneau, Anke Rissmann, Mary O'Mahony, Joanna Sichitiu, Elisa Ballardini, Alessio Coi, Clara Cavero Carbonell, Joan Morris
Förderung
- Medical Research Council
Zitieren
APA
Johnson, H., Dolk, H., Loane, M., Damase-Michel, C., Given, J., Nordeng, H., Bergman, J. E. H., Carey, I., Den Hond, E., Garne, E., Rouget, F., Bruneau, L., Monier, I., Rissmann, A., O'Mahony, M., Gatt, M., Lutke, R., Sichitiu, J., Ballardini, E., …, & Morris, J. (2026). Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy. British Journal of Clinical Pharmacology, 92(10), 3586-3597. https://doi.org/10.1002/bcp.70645
Vancouver
Johnson H, Dolk H, Loane M, Damase-Michel C, Given J, Nordeng H, et al. Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy. British Journal of Clinical Pharmacology. 2026;92(10):3586-3597. doi:10.1002/bcp.70645
BibTeX
@article{Johnson2026,
author = {Johnson, Hannah and Dolk, Helen and Loane, Maria and Damase-Michel, Christine and Given, Joanne and Nordeng, Hedvig and Bergman, Jorieke E H and Carey, Iain and Den Hond, Elly and Garne, Ester and Rouget, Florence and Bruneau, Lea and Monier, Isabelle and Rissmann, Anke and O'Mahony, Mary and Gatt, Miriam and Lutke, Renée and Sichitiu, Joanna and Ballardini, Elisa and Coi, Alessio and Cavero Carbonell, Clara and Tucker, David and Morris, Joan},
title = {Case‐malformed signal detection and prioritisation using EUROmediCAT data for pharmacovigilance in pregnancy},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
volume = {92},
number = {10},
pages = {3586--3597},
doi = {10.1002/bcp.70645}
}
EUVIMED